Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Met inhibitor JNJ-38877605 advanced to clinical evaluation for metastasized malignancies

April 28, 2008

Epeius presents results from phase I/II clinical trial of Rexin-G for pancreatic cancer

April 25, 2008

NovaRx's cancer vaccine enters phase III evaluation for NSCLC

April 25, 2008

Monoclonal antibody against AMIGO-2 inhibits pancreatic tumor growth in vivo

April 25, 2008

Pim kinase inhibitor SGI-1776 induces apoptosis in cancer cells

April 25, 2008

AFM-13 acts according to expectations in preclinical studies

April 25, 2008

PharmaGap reports results from animal studies of PhG-alpha1 for cancer

April 25, 2008

FDA approves Calando's IND application for siRNA nanoparticle therapeutic CALAA-01

April 24, 2008

AEterna Zentaris develops new cytotoxic conjugate, AEZS-125

April 24, 2008

MI-219 displays preclinical anticancer activity

April 24, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...